S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Saudi Aramco's profits already $88B as oil prices stay high
Biden's Plan to Confiscate Your Cash? (Ad)
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Biden's Plan to Confiscate Your Cash? (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Saudi Aramco's profits already $88B as oil prices stay high
Biden's Plan to Confiscate Your Cash? (Ad)
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Biden's Plan to Confiscate Your Cash? (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Saudi Aramco's profits already $88B as oil prices stay high
Biden's Plan to Confiscate Your Cash? (Ad)
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Biden's Plan to Confiscate Your Cash? (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Saudi Aramco's profits already $88B as oil prices stay high
Biden's Plan to Confiscate Your Cash? (Ad)
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Biden's Plan to Confiscate Your Cash? (Ad)
NASDAQ:QNRX

Quoin Pharmaceuticals - QNRX News Headlines

$4.78
-0.04 (-0.83%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
$4.70
$5.09
50-Day Range
$3.85
$19.80
52-Week Range
$3.58
$444.00
Volume
809,924 shs
Average Volume
4.00 million shs
Market Capitalization
$3.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$50.00
Get Quoin Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for QNRX and its competitors with MarketBeat's FREE daily newsletter.

QNRX Media Mentions By Week

QNRX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

QNRX
News Sentiment

1.07

0.63

Average
Medical
News Sentiment

QNRX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

QNRX Articles
This Week

5

1

QNRX Articles
Average Week



SourceHeadline
finance.yahoo.com logoQuoin Pharmaceuticals to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 18th
finance.yahoo.com - August 11 at 7:25 PM
MarketBeat logoICU Medical (NASDAQ:ICUI) & Quoin Pharmaceuticals (NASDAQ:QNRX) Head to Head Review
americanbankingnews.com - August 10 at 2:00 AM
finance.yahoo.com logoQuoin Pharmaceuticals Announces Closing of $16.8 Million Public Offering
finance.yahoo.com - August 9 at 4:44 PM
finance.yahoo.com logoQuoin Pharmaceuticals Announces Pricing of $16.8 Million Upsized Public Offering
finance.yahoo.com - August 5 at 12:43 PM
investorplace.com logoWhat Is Going on With Quoin Pharmaceuticals (QNRX) Stock?
investorplace.com - August 4 at 1:13 PM
finance.yahoo.com logoQuoin Pharmaceuticals Announces Receipt of Constructive Scientific Advice from EMA for QRX003 Development in Europe
finance.yahoo.com - July 28 at 1:06 PM
MarketBeat logoQuoin Pharmaceuticals Stock to Reverse Split on Monday, August 1st (NASDAQ:QNRX)
americanbankingnews.com - July 20 at 1:22 AM
nasdaq.com logoEndo In Deal With Quoin Pharmaceuticals To Develop And Sell Quoin's QRX003 In Canada
nasdaq.com - July 15 at 12:39 PM
finance.yahoo.com logoQuoin Pharmaceuticals and Endo Ventures Limited Enter Into Exclusive Distribution and Supply Agreements
finance.yahoo.com - July 15 at 12:39 PM
finanznachrichten.de logoEndo International plc: Endo Announces Agreement for Paladin Labs to Develop, Commercialize and Supply Quoin Pharmaceuticals' QRX003 in Canada
finanznachrichten.de - July 15 at 7:38 AM
finance.yahoo.com logoEndo Announces Agreement for Paladin Labs to Develop, Commercialize and Supply Quoin Pharmaceuticals' QRX003 in Canada
finance.yahoo.com - July 15 at 7:38 AM
finance.yahoo.com logoQuoin Pharmaceuticals Announces Opening of First Clinical Site for Netherton Syndrome Clinical Study
finance.yahoo.com - July 6 at 9:40 AM
investorplace.com logoWhy Is Quoin Pharmaceuticals (QNRX) Stock Up 93% Today?
investorplace.com - July 1 at 10:12 AM
seekingalpha.com logoQuoin Pharmaceuticals gets Nasdaq notification on minimum bid price requirement
seekingalpha.com - June 15 at 8:54 PM
finance.yahoo.com logoQuoin Pharmaceuticals Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
finance.yahoo.com - June 15 at 8:54 PM
seekingalpha.com logoQuoin secures licensing & distribution deal for its skin disorder treatments for China
seekingalpha.com - June 15 at 10:49 AM
finance.yahoo.com logoQuoin Pharmaceuticals Announces Licensing and Distribution Agreement with Leading Rare Disease Company for Greater China
finance.yahoo.com - June 15 at 10:49 AM
finance.yahoo.com logoQuoin Pharmaceuticals: Strategically Building For Future Success
finance.yahoo.com - June 14 at 9:35 AM
finance.yahoo.com logoWhy Are Quoin Pharma Shares Trading Higher Today?
finance.yahoo.com - June 6 at 4:19 PM
finance.yahoo.com logoSkinvisible Announces First Invisicare Delivery Technology Product to Receive U.S. FDA Acceptance of Investigational New Drug
finance.yahoo.com - June 6 at 11:19 AM
finance.yahoo.com logoQuoin Pharmaceuticals Enters Exclusive Research Agreement for Scleroderma Treatment with Australian University
finance.yahoo.com - May 23 at 7:15 PM
finance.yahoo.com logoQuoin Pharmaceuticals: On Track to Deliver the First FDA-Approved Treatment for Netherton Syndrome
finance.yahoo.com - May 17 at 12:14 PM
finance.yahoo.com logoWhen Will Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) Breakeven?
finance.yahoo.com - May 11 at 2:48 PM
uk.investing.com logoWhy Quoin Pharmaceuticals Stock Is Trading Higher
uk.investing.com - April 25 at 6:33 PM
finance.yahoo.com logoQNRX: FDA Clearance To Move QRX003 Clinical Testing Forward; Positive Implications
finance.yahoo.com - April 25 at 6:32 PM
seekingalpha.com logoQuoin soars on FDA clearance to start testing of its QRX003 lotion for rare skin disorder
seekingalpha.com - April 25 at 1:32 PM
finance.yahoo.com logoQuoin Pharmaceuticals Announces FDA Clearance of IND for its Lead Asset, QRX003, for Netherton Syndrome
finance.yahoo.com - April 25 at 1:32 PM
seekingalpha.com logoQuoin Pharma targets regulatory nod for lead asset in 2024
seekingalpha.com - March 24 at 10:28 AM
finance.yahoo.com logoQuoin Pharmaceuticals Targeting Regulatory Approvals for Lead Candidate for Netherton Syndrome in 2024
finance.yahoo.com - March 24 at 10:28 AM
finance.yahoo.com logoQuoin Pharmaceuticals Announces Submission of IND for its Lead Asset, QRX003, for Netherton Syndrome
finance.yahoo.com - March 15 at 1:41 PM
finance.yahoo.com logoQuoin Pharmaceuticals Submits Scientific Advice Briefing Document to EMA for its Lead Asset, QRX003, for Netherton Syndrome
finance.yahoo.com - March 10 at 10:53 AM
seekingalpha.com logoQuoin stock rises after expanding distribution deal with ER-Kim for QRX003
seekingalpha.com - March 1 at 4:39 PM
finance.yahoo.com logoQuoin Pharmaceuticals Extends Exclusive Distribution Agreement with ER-Kim for its Lead Asset, QRX003, for Netherton Syndrome
finance.yahoo.com - March 1 at 11:39 AM
finance.yahoo.com logoQuoin Pharmaceuticals Signs Exclusive Distribution Agreement with Neopharm for its Lead Asset, QRX003, for Netherton Syndrome
finance.yahoo.com - February 17 at 12:55 PM
seekingalpha.com logoQuoin Pharmaceuticals inks distribution deal for QRX003 for Netherton syndrome
seekingalpha.com - February 10 at 5:42 PM
finance.yahoo.com logoQuoin Pharmaceuticals Signs Exclusive Distribution Agreement with ER-Kim for its Lead Asset, QRX003, for Netherton Syndrome
finance.yahoo.com - February 10 at 5:42 PM
finance.yahoo.com logoChanging Lives, Delivering Value: Quoin Pharmaceuticals is Making the Balancing Act Look Easy
finance.yahoo.com - February 8 at 1:00 PM
finance.yahoo.com logoQuoin Pharmaceuticals Signs Exclusive Distribution Agreement with OrphanDC for its Lead Asset, QRX003, for Netherton Syndrome
finance.yahoo.com - January 26 at 9:49 AM
nasdaq.com logoQuoin Pharmaceuticals Ltd. Rings the Closing Bell
nasdaq.com - January 24 at 6:08 PM
nasdaq.com logoQuoin Pharmaceuticals Ltd. Rings The Nasdaq Stock Market Closing Bell
nasdaq.com - January 24 at 6:08 PM
finance.yahoo.com logoQNRX: Laying the Groundwork to Launch Multiple Treatments for Rare & Orphan Diseases
finance.yahoo.com - January 24 at 1:08 PM
reuters.com logoQuoin Pharmaceuticals Ltd - ADR
reuters.com - December 22 at 6:02 PM
finance.yahoo.com logoQuoin Pharmaceuticals Signs Exclusive Distribution Agreement with Orpharm LLC for its Lead Asset, QRX003, for Netherton Syndrome
finance.yahoo.com - December 15 at 10:53 AM
finance.yahoo.com logoThe R&D Sweet Spot: Quoin Pharmaceuticals Delivering Value-Based Drug Development Through Rare and Orphan Disease Therapeutics
finance.yahoo.com - December 14 at 1:22 PM
finance.yahoo.com logoQuoin Pharmaceuticals Poised for Rapid Commercialization of Promising Pipeline
finance.yahoo.com - November 16 at 8:58 AM
wsj.com logoQuoin Pharmaceuticals Ltd. ADR
wsj.com - November 13 at 7:23 AM
finance.yahoo.com logoQuoin Pharmaceuticals and Genpharm Services Sign Exclusive License and Distribution Agreement for Quoin’s Lead Asset, QRX003
finance.yahoo.com - November 11 at 12:44 PM
benzinga.com logoQuoin Outlicenses Lead Asset For Skin Disorder In Middle East, North Africa
benzinga.com - November 11 at 12:16 PM
Get Quoin Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for QNRX and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:QNRX) was last updated on 8/14/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.